位置:首页 > 蛋白库 > ZNRF2_HUMAN
ZNRF2_HUMAN
ID   ZNRF2_HUMAN             Reviewed;         242 AA.
AC   Q8NHG8;
DT   20-FEB-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 155.
DE   RecName: Full=E3 ubiquitin-protein ligase ZNRF2;
DE            EC=2.3.2.27;
DE   AltName: Full=Protein Ells2;
DE   AltName: Full=RING finger protein 202;
DE   AltName: Full=RING-type E3 ubiquitin transferase ZNRF2;
DE   AltName: Full=Zinc/RING finger protein 2;
GN   Name=ZNRF2; Synonyms=RNF202;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, MYRISTOYLATION AT GLY-2, SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=14561866; DOI=10.1523/jneurosci.23-28-09385.2003;
RA   Araki T., Milbrandt J.;
RT   "ZNRF proteins constitute a family of presynaptic E3 ubiquitin ligases.";
RL   J. Neurosci. 23:9385-9394(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary;
RA   Guo J.H., Yu L.;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [4]
RP   INTERACTION WITH UBE2N.
RX   PubMed=16215985; DOI=10.1002/jcb.20587;
RA   Plans V., Scheper J., Soler M., Loukili N., Okano Y., Thomson T.M.;
RT   "The RING finger protein RNF8 recruits UBC13 for lysine 63-based self
RT   polyubiquitylation.";
RL   J. Cell. Biochem. 97:572-582(2006).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND SER-151, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-113 AND SER-116, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND SER-135, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND SER-135, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-135 AND SER-193, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-89 AND SER-135, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May play a role in the establishment and maintenance of
CC       neuronal transmission and plasticity via its ubiquitin ligase activity.
CC       E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating
CC       enzyme in the form of a thioester and then directly transfer the
CC       ubiquitin to targeted substrates. {ECO:0000269|PubMed:14561866}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with UBE2N. {ECO:0000269|PubMed:16215985}.
CC   -!- SUBCELLULAR LOCATION: Endosome membrane {ECO:0000269|PubMed:14561866};
CC       Peripheral membrane protein {ECO:0000269|PubMed:14561866}. Lysosome
CC       membrane {ECO:0000269|PubMed:14561866}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:14561866}. Presynaptic cell membrane
CC       {ECO:0000269|PubMed:14561866}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:14561866}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in the brain, with higher
CC       expression during development than in adult. Expressed also in mammary
CC       glands, testis, colon and kidney. {ECO:0000269|PubMed:14561866}.
CC   -!- DOMAIN: The RING-type zinc finger domain is required for E3 ligase
CC       activity. {ECO:0000250}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF513707; AAQ08115.1; -; mRNA.
DR   EMBL; AF527533; AAM88868.1; -; mRNA.
DR   CCDS; CCDS5426.1; -.
DR   RefSeq; NP_667339.1; NM_147128.3.
DR   AlphaFoldDB; Q8NHG8; -.
DR   SMR; Q8NHG8; -.
DR   BioGRID; 128825; 54.
DR   IntAct; Q8NHG8; 5.
DR   MINT; Q8NHG8; -.
DR   STRING; 9606.ENSP00000323879; -.
DR   iPTMnet; Q8NHG8; -.
DR   PhosphoSitePlus; Q8NHG8; -.
DR   BioMuta; ZNRF2; -.
DR   DMDM; 74762595; -.
DR   EPD; Q8NHG8; -.
DR   jPOST; Q8NHG8; -.
DR   MassIVE; Q8NHG8; -.
DR   MaxQB; Q8NHG8; -.
DR   PaxDb; Q8NHG8; -.
DR   PeptideAtlas; Q8NHG8; -.
DR   PRIDE; Q8NHG8; -.
DR   ProteomicsDB; 73707; -.
DR   Antibodypedia; 35132; 121 antibodies from 25 providers.
DR   DNASU; 223082; -.
DR   Ensembl; ENST00000323037.5; ENSP00000323879.4; ENSG00000180233.11.
DR   GeneID; 223082; -.
DR   KEGG; hsa:223082; -.
DR   MANE-Select; ENST00000323037.5; ENSP00000323879.4; NM_147128.4; NP_667339.1.
DR   UCSC; uc003tat.3; human.
DR   CTD; 223082; -.
DR   DisGeNET; 223082; -.
DR   GeneCards; ZNRF2; -.
DR   HGNC; HGNC:22316; ZNRF2.
DR   HPA; ENSG00000180233; Low tissue specificity.
DR   MIM; 612061; gene.
DR   neXtProt; NX_Q8NHG8; -.
DR   OpenTargets; ENSG00000180233; -.
DR   PharmGKB; PA134961488; -.
DR   VEuPathDB; HostDB:ENSG00000180233; -.
DR   eggNOG; KOG0801; Eukaryota.
DR   GeneTree; ENSGT00940000159017; -.
DR   HOGENOM; CLU_062700_2_0_1; -.
DR   InParanoid; Q8NHG8; -.
DR   OMA; SEEMDLH; -.
DR   OrthoDB; 1256682at2759; -.
DR   PhylomeDB; Q8NHG8; -.
DR   TreeFam; TF317681; -.
DR   PathwayCommons; Q8NHG8; -.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q8NHG8; -.
DR   UniPathway; UPA00143; -.
DR   BioGRID-ORCS; 223082; 12 hits in 1083 CRISPR screens.
DR   ChiTaRS; ZNRF2; human.
DR   GenomeRNAi; 223082; -.
DR   Pharos; Q8NHG8; Tbio.
DR   PRO; PR:Q8NHG8; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q8NHG8; protein.
DR   Bgee; ENSG00000180233; Expressed in buccal mucosa cell and 152 other tissues.
DR   ExpressionAtlas; Q8NHG8; baseline and differential.
DR   Genevisible; Q8NHG8; HS.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0042995; C:cell projection; IEA:UniProtKB-KW.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005765; C:lysosomal membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:MGI.
DR   GO; GO:0042734; C:presynaptic membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IDA:MGI.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IBA:GO_Central.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF13639; zf-RING_2; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Cell projection; Endosome; Lipoprotein; Lysosome; Membrane;
KW   Metal-binding; Myristate; Phosphoprotein; Reference proteome; Synapse;
KW   Transferase; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   CHAIN           2..242
FT                   /note="E3 ubiquitin-protein ligase ZNRF2"
FT                   /id="PRO_0000277803"
FT   ZN_FING         199..240
FT                   /note="RING-type; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   REGION          1..141
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        18..33
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        95..120
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71FD5"
FT   MOD_RES         25
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71FD5"
FT   MOD_RES         82
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         89
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         116
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         135
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         145
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q71FD5"
FT   MOD_RES         151
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         193
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   LIPID           2
FT                   /note="N-myristoyl glycine"
FT                   /evidence="ECO:0000305|PubMed:14561866"
SQ   SEQUENCE   242 AA;  24115 MW;  D02776578A1E9E55 CRC64;
     MGAKQSGPAA ANGRTRAYSG SDLPSSSSGG ANGTAGGGGG ARAAAAGRFP AQVPSAHQPS
     ASGGAAAAAA APAAPAAPRS RSLGGAVGSV ASGARAAQSP FSIPNSSSGP YGSQDSVHSS
     PEDGGGGRDR PVGGSPGGPR LVIGSLPAHL SPHMFGGFKC PVCSKFVSSD EMDLHLVMCL
     TKPRITYNED VLSKDAGECA ICLEELQQGD TIARLPCLCI YHKGCIDEWF EVNRSCPEHP
     SD
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024